Skip to main content

Pramipexole (International)

In the US, Pramipexole (pramipexole systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease, Periodic Limb Movement Disorder, Restless Legs Syndrome and Tardive Dyskinesia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N04BC05

CAS registry number (Chemical Abstracts Service)

0104632-26-0

Chemical Formula

C10-H17-N3-S

Molecular Weight

211

Therapeutic Categories

Treatment of Parkinson's disease

Dopamine agonist

Chemical Name

2,6-Benzotiazolediamine, 4,5,6,7-tetrahydro-N⁶-propyl-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs